HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Co-Aggregation of S100A9 with DOPA and Cyclen-Based Compounds Manifested in Amyloid Fibril Thickening without Altering Rates of Self-Assembly.

Abstract
The amyloid cascade is central for the neurodegeneration disease pathology, including Alzheimer's and Parkinson's, and remains the focus of much current research. S100A9 protein drives the amyloid-neuroinflammatory cascade in these diseases. DOPA and cyclen-based compounds were used as amyloid modifiers and inhibitors previously, and DOPA is also used as a precursor of dopamine in Parkinson's treatment. Here, by using fluorescence titration experiments we showed that five selected ligands: DOPA-D-H-DOPA, DOPA-H-H-DOPA, DOPA-D-H, DOPA-cyclen, and H-E-cyclen, bind to S100A9 with apparent Kd in the sub-micromolar range. Ligand docking and molecular dynamic simulation showed that all compounds bind to S100A9 in more than one binding site and with different ligand mobility and H-bonds involved in each site, which all together is consistent with the apparent binding determined in fluorescence experiments. By using amyloid kinetic analysis, monitored by thioflavin-T fluorescence, and AFM imaging, we found that S100A9 co-aggregation with these compounds does not hinder amyloid formation but leads to morphological changes in the amyloid fibrils, manifested in fibril thickening. Thicker fibrils were not observed upon fibrillation of S100A9 alone and may influence the amyloid tissue propagation and modulate S100A9 amyloid assembly as part of the amyloid-neuroinflammatory cascade in neurodegenerative diseases.
AuthorsLili Arabuli, Igor A Iashchishyn, Nina V Romanova, Greta Musteikyte, Vytautas Smirnovas, Himanshu Chaudhary, Željko M Svedružić, Ludmilla A Morozova-Roche
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 22 Issue 16 (Aug 09 2021) ISSN: 1422-0067 [Electronic] Switzerland
PMID34445262 (Publication Type: Journal Article)
Chemical References
  • Amyloid
  • Calgranulin B
  • Protein Aggregates
  • S100A9 protein, human
  • Dihydroxyphenylalanine
Topics
  • Amyloid (chemistry)
  • Calgranulin B (chemistry)
  • Dihydroxyphenylalanine (chemistry)
  • Humans
  • Molecular Dynamics Simulation
  • Protein Aggregates

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: